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1. Introduction 
Bariatric surgery is an important option for patients with extreme obesity and co-
morbidities. Bariatric surgery, however, has risks and complications involved. Obesity is 
associated with many health related complications such as cardiovascular disease, type 2 
diabetes mellitus, dyslipidaemia, hypertension, and obstructive sleep apnoea (Avenell, 
Broom et al. 2004; Tsigos, Hainer et al. 2008; Mechanick, Kushner et al. 2009; Scottish 
Intercollegiate Guidelines and Scotland 2010). It is important to prepare patients to be at 
their best medical status prior to surgery to prevent adverse outcomes (Mechanick, Kushner 
et al. 2009). Detailed medical, nutritional and psychological assessments are crucial to 
improve patients’ outcomes post surgery. This usually involves a multidisciplinary team 
working hand in hand with individual patients guiding them through the whole process as 
well as continuing lifelong follow up care. A multidisciplinary team usually includes a 
physician with interest in metabolism, nutrition and bariatric medicine, dietitian with 
special interest in obesity, a bariatric surgeon, a bariatric specialist nurse and psychologist, 
and finally a bariatric coordinator (Mechanick, Kushner et al. 2009). Additional expertise 
includes a psychiatrist, endocrinologist, sleep medicine specialist, cardiologist, 
gastroenterologist, physician nutrition specialist and certified nutrition support clinician 
(Mechanick, Kushner et al. 2009). However, the most important factor in the entire process is 
the individual patient and therefore it is important to individualise each patient’s care. Good 
medical assessment with appropriate information provided for patients will help ease 
progress through bariatric surgery. 
2. Patients’ motivation and expectations 
Patients undergo bariatric surgical procedures for different reasons. It is important to 
understand each patient’s expectations prior to surgery. Studies have shown improvements 
in psychological or physical health, better quality of life and self esteem as well as better 
emotional satisfaction in relation with food post operatively (Wolfe and Terry 2006). 
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However, there is no gain in romantic and professional relationships post surgery (Wolfe 
and Terry 2006) and patients should be warned and be prepared for this. 
Bariatric surgery offers reduction in body weight of between 20-32% within 2 years and 
between 10-25% after 10 year (Sjostrom, Narbro et al. 2007), or a reduction of 55.9% in excess 
weight within 2 years(Buchwald, Estok et al. 2009). Studies have shown of the discrepancies 
in opinion between medical professionals of a successful surgical outcome and patients’ 
expectations (Foster, Wadden et al. 2001; Wee, Jones et al. 2006; Mechanick, Kushner et al. 
2009; Heinberg, Keating et al. 2010). One study showed that the average patient ‘dream’ 
weight loss is 55kg, attributing to 94% of excess weight loss or losing 43% of their pre-
surgical weight. About 90% of the patients in the study were willing to risk death in order 
achieve their ‘dream’ weight and almost all patients were willing to risk dying to have a 
perfect health and their ‘dream’ weight (Wee, Jones et al. 2006). Younger, Caucasian females 
with higher body mass index are more likely to have unrealistic expectations (Heinberg, 
Keating et al. 2010). The team will need to work with patients and provide clear 
understanding and information regarding realistic outcomes (Tsigos, Hainer et al. 2008) 
prior to surgery. The team will need to work with patients to negotiate achievable end 
points and set small feasible goals during the short term period. Providing good education 
and developing good relationships with patients are vital as this enhances compliance in the 
future. 
Apart from patients’ expectation, patients’ attitude towards weight loss is also important. It 
has been shown that 2 years post bariatric surgery, dietary changes and physical activity 
become lax and patients start to gain weight (Sjostrom, Lindroos et al. 2004). The team will 
need to assess their likelihood and willingness to make life long changes in their eating 
habits and engagement in physical activities (National Heart, Blood et al. 1998; UK 2007; 
Tsigos, Hainer et al. 2008; Scottish Intercollegiate Guidelines and Scotland 2010) to prevent 
further weight gain pre or post surgery. Motivation could change over time due to various 
influences (UK 2007). Understanding the medical consequences of obesity will help 
motivate patients. Other areas to assess motivation are the likelihood to attend follow up 
appointments, potential barriers to initiate weight loss such as lack of self esteem or 
confidence in themselves and potential support from family and friends (National Heart, 
Blood et al. 1998). 
3. Medical assessment 
3.1 Clinic set up 
Clinic set up is important to provide a safe and friendly environment for patients. Entrances 
and rooms should be spacious enough for bariatric wheel chair access. Chairs in the waiting 
area and in clinic rooms should provide armless bariatric chair (Mechanick, Kushner et al. 
2009). Wheelchairs availability in hospital should accommodate both the weight and size of 
patients (Barr and Cunneen 2001). Other essential patient care equipments such as suitable 
examination table in the clinic room, appropriate weighing scales and stadiometer should be 
available (Mechanick, Kushner et al. 2009). Facilities such as toilets should not be 
overlooked and fixtures to help individuals with mobility problems may need to be adapted 
for bariatric patients (Barr and Cunneen 2001). 
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3.2 Medical history 
A thorough medical history and good physical examination will help identify potential 
health problems. The most important history will be the patient’s eating behaviour covering 
their history of weight gain and previous attempts for weight loss (Tsigos, Hainer et al. 2008; 
Mechanick, Kushner et al. 2009). History of weight gain, detailed food history and amount 
of physical activity is also important. Onset of weight gain could be a consequence of 
various factors including marriage, pregnancy, and smoking cessation, stress or drug 
induced. Eating patterns and dietary habits are useful to help exclude eating disorders 
(Tsigos, Hainer et al. 2008) and this will be covered in the nutritional and psychological 
section. 
History should be holistic, including respiratory, cardiovascular, neurological, 
gastrointestinal, endocrine, musculoskeletal and genital urinary systems including sexual 
history. Medication and drug histories are also important as many drugs causes weight 
gain. It is also important to include usage of illegal drugs and over the counter medication. 
All past medical history must include mood disorders or other mental health illness 
(Mechanick, Kushner et al. 2009) as well as family history. 
Apart from medical history, it is also essential to obtain the patient’s functional status 
including activities of daily living. It is also important to ask about social history including 
support available either by family members or friends if patient is deemed suitable for 
surgery (Mechanick, Kushner et al. 2009). Occupation, alcohol and smoking histories should 
not be missed (Mechanick, Kushner et al. 2009). The patient should be advised to stop 
smoking but this should be monitored closely as quitting smoking is associated with 
weight gain. This holistic approach will paint a better picture of how obesity is affecting 
the patient. Patients with excessive alcohol intake need to be advised to return to 
recommended levels. 
3.3 Physical examination 
Physical examination should be thorough including all anthropometric measurement of 
height and weight to obtain body mass index (Mechanick, Kushner et al. 2009), and waist 
circumference. Cardiovascular, respiratory, neurology and abdominal systems should be 
assessed. Neck circumference is an important assessment for obstructive sleep apnoea 
(Scottish Intercollegiate Guidelines 2003; Epstein, Kristo et al. 2009). Acanthosis nigricans is a 
sign for insulin resistance (Tsigos, Hainer et al. 2008; Mechanick, Kushner et al. 2009). Other 
signs include striae distensae (stretch mark), lymphoedema, stasis pigmentation of the lower 
limbs, intertrigo, hidradenitis suppurativa and acrochordon (Mechanick, Kushner et al. 
2009). In patients with history of uncontrolled hypertension and insulin resistance, 
Cushing’s syndrome should be excluded. Signs of Cushing’s syndrome are moon facies, 
posterior cervical fat pads, easy bruisability and purple striae on the abdomen. These signs 
are, however, rarely seen in clinical bariatric practice. 
3.4 Investigations 
All patients should have routine blood tests to screen for any potential health problems and 
treat accordingly prior to surgery (Mechanick, Kushner et al. 2009). 
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 Full blood count   Anaemia 
 Renal function    Kidney disease, hypo or hyperkalaemia 
 Liver function test   Hepatitis, non alcoholic induced fatty liver (see 
     lower section) 
 Coagulation profile   Coagulopathy, bleeding disorder 
 Fasting glucose    Diabetes mellitus (see lower section) 
 HbA1c    Diabetes mellitus (see lower section) 
 Fasting lipid profile   Dyslipidaemia 
 Urine pregnancy test   Pregnancy 
If secondary causes of obesity are suspected, patient should be evaluated for primary 
endocrine disorder such as hypothyroidism and Cushing’s syndrome (Tsigos, Hainer et al. 
2008; Mechanick, Kushner et al. 2009). Screening tests for these are as below (Mechanick, 
Kushner et al. 2009): 
 Hypothyroidism  Thyroid function test 
 Cushing’s syndrome  Bedtime salivary cortisol level or 
    1mg low dose dexamethasone suppression test or 
    24 hour urine cortisol excretion 
Interpretation of tests for Cushing’s syndrome can be difficult and more detailed tests may 
be required. There is no indication for routine testing in this patient population. Only 
patients with indicative signs, history (including relevant metabolic and cardiovascular 
abnormalities) and where there is an inability to lose weight despite maximal effort, should 
be investigated. 
Any patients undergoing malabsorptive procedure should have their micronutrients status 
checked prior to surgery and any deficiencies should be corrected (Mechanick, Kushner et 
al. 2009). If there is an indication of celiac disease based on these investigations, specific 
coeliac disease investigations should be carried out. 
 Iron status     Iron deficiency anaemia 
(total iron binding capacity, ferritin, iron, transferring receptor) 
 Vitamin B12 level   Pernicious anaemia, Vitamin B12 deficiency 
 25-OH Vitamin D   Vitamin D deficiency 
 Parathyroid hormone (PTH)  Vitamin D deficiency 
 Folate levels    Folic acid deficiency, hyperhomocysteinaemia 
 Bone profile    Hypocalcaemia, hypophosphataemia 
 Magnesium     Hypomagnesaemia 
Testing for PTH can be costly and should only be undertaken if there are indications based 
on other test results. 
4. Review of systems 
4.1 Respiratory status 
Chest x-ray has been recommended to be done for all patients to exclude any pulmonary 
disorders (Mechanick, Kushner et al. 2009). Chest X-ray, and indeed any imaging 
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investigations are difficult to conduct and interpret in this patient population and may not 
provide any additional information. Any patients with previous history of respiratory 
disorder should have arterial blood gas and undergo pulmonary function tests (Mechanick, 
Kushner et al. 2009). Arterial gases are also useful for assessment of the obesity 
hypoventilation syndrome. Advising patient to quit smoking will help reduce peri-operative 
respiratory complications (Mechanick, Kushner et al. 2009). 
4.1.1 Lung function in obesity 
Breathlessness is a very common symptom among obese patients. It is shown that obesity 
could affect respiratory physiology including reduction in respiratory compliance and 
respiratory muscle strength (McClean, Kee et al. 2008; Sood 2009). In fact, many obese 
patients have problems with their respiratory function. If cardiac causes have been excluded 
and the patient is complaining of breathlessness, lung function and exercise tests are useful 
investigations to assess and rule out other significant respiratory problems such as chronic 
obstructive airway disease or asthma. 
At baseline, pulmonary function tests are different between an obese patient and one with 
normal body mass index. The most significant difference in an obese patient is the reduction 
in functional residual capacity (FRC) and expiratory reserve volume (ERV) (Gibson 2000; 
Jones and Nzekwu 2006; Sood 2009). The higher the body mass index, the greater the effect 
of reduction (Jones and Nzekwu 2006) hence increasing the work of breathing at rest leading 
to dyspnoea. This can be explained by the effects of abdominal distension from visceral fat 
on the diaphragm (Gibson 2000; Rabec, de Lucas Ramos et al. 2011) as well as the reduction 
in chest wall distensibility (Jones and Nzekwu 2006; Rabec, de Lucas Ramos et al. 2011). 
There may also be an association in the reduction of forced expiratory volume in 1 second 
(FEV1) (McClean, Kee et al. 2008; Sood 2009; Rabec, de Lucas Ramos et al. 2011). 
4.1.2 Obstructive sleep apnoea (OSA) 
Obstructive sleep apnoea (OSA) is a condition characterised by episodic complete or partial 
obstruction of the upper airway during sleep (Rabec, de Lucas Ramos et al. 2011). Obesity is 
one of the major risk factor for developing OSA. There is an increased in subcutaneous and 
periluminal fat causing narrowing of the pharynx leading to obstruction (Epstein, Kristo et 
al. 2009). This could cause difficulties during peri-operative airway management 
(Mechanick, Kushner et al. 2009) and presence of OSA has been shown in LABS study to 
increase 30 day operative mortality (Flum, Belle et al. 2009) hence the importance of the 
diagnosis leading to more stringent perioperative care of these individuals. About 40% of 
obese patients suffer with OSA (Sood 2009) and the prevalence can be as high as 98% in the 
morbidly obese patients (Valencia-Flores, Orea et al. 2000). 
Excessive daytime somnolence, snoring at night, feeling unrefreshed on waking, restless 
sleep, impaired concentration, irritability and apnoeic episodes during sleep are some of the 
common symptoms of OSA. It has been recommended that all obese patients should be 
assessed to exclude OSA either by respiratory physician or use the validated questionnaires 
such as the Epworth’s Sleepiness Score (ESS) (Johns 1991) or the Berlin Questionnaire 
(Netzer, Stoohs et al. 1999) The ESS should be completed by both the patient and the partner 
if possible. ESS has a maximum score of 24 and a score of > 18 is suggestive of severe 
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subjective daytime somnolence, score of between 15 and 18 is moderate while score of 
between 11 and 14 is mild (Scottish Intercollegiate Guidelines 2003). Berlin questionnaire 
looked at 3 different categories; which are snoring, wake time sleepiness or drowsy driving 
and hypertension or obesity. High risk for OSA is defined as persistent symptoms in at least 
2 of the categories with a sensitivity of 86% and specificity of 77% (Netzer, Stoohs et al. 
1999). In our experience, the Berlin and Epworth questionnaires are not good indicators of 
OSA and we recommend formal evaluation for OSA in all bariatric patients. 
All patients should undergo sleep studies depending on facilities available. 
Polysomnography is the investigation of choice to assess OSA and it consists of 
electroencephalogram (EEG), electroculogram (EOG), chin electromyogram, oxygen 
saturation, respiratory airflow, thoracic movements and electrocardiography (ECG) 
(Scottish Intercollegiate Guidelines 2003; Epstein, Kristo et al. 2009). Body position and 
snoring is monitored as well (Scottish Intercollegiate Guidelines 2003; Epstein, Kristo et al. 
2009). Overnight monitoring is ideal and results will then be interpreted. If a full 
polysomnography is not available, then the sleep study usually consists of respiratory 
assessment, thoraco-abdominal movement, and monitor for snoring episodes (Scottish 
Intercollegiate Guidelines 2003). In-laboratory polysomnography may not be routinely 
available to all patients due to high cost and technical complexity (Collop, Anderson et al. 
2007). In that case, unattended portable monitors could be alternative choice. American 
Academy of Sleep Medicine guideline stated the use of portable monitors should be ‘in 
conjunction with a comprehensive sleep evaluation’ for ‘patients with high pretest 
probability of or moderate to severe OSA’ who do not have significant co-morbidies such as 
severe pulmonary disease, neuromuscular disease or congestive heart failure (Collop, 
Anderson et al. 2007). 
The aim of polysomnography is to measure apnoea or hypopnoea episodes. These episodes 
are reported as apnoea/hypopnoea index (AHI) or respiratory disturbance index (RDI) and 
can be divided into (Scottish Intercollegiate Guidelines 2003; Epstein, Kristo et al. 2009): 
 Mild  OSA  AHI/RDI  5 – 14 per hour 
 Moderate  OSA  AHI/RDI  15-30 per hour 
 Severe OSA  AHI/RDI  > 30 per hour 
Treatment for OSA is weight reduction hence bariatric surgery could help the condition. 
Non surgical treatment of OSA includes continuous positive airway pressures. Positive 
airway pressure can be continuous (CPAP), autotitrating (APAP) or bilevel (BPAP) (Scottish 
Intercollegiate Guidelines 2003; Epstein, Kristo et al. 2009). Sedatives and alcohol should be 
avoided in the evenings and at night as they reduce airway dilator function hence 
worsening of OSA (Scottish Intercollegiate Guidelines 2003). Post-operatively, these patients 
need to be monitored closely and to continue to use their positive airway pressure 
appliances (Mechanick, Kushner et al. 2009). There is debate regarding duration of CPAP 
use prior to operation (some centres recommending 3 months), peri-operatively (theoretical 
potential to disturb anastomoses in non gastric band operations), and post-operatively. 
4.1.3 Obesity hypoventilation syndrome (OHS) 
Obesity hypoventilation syndrome is a diagnosis of exclusion. The definition of OHS is a 
condition of consists of daytime hypercapnia and hypoxemia, sleep disordered breathing 
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and obese patient (Mokhlesi 2010). The majority of OHS patients will also have OSA. 
Other respiratory conditions including intrinsic respiratory disorders, central 
hypoventilation syndromes and neuromuscular disorders should be excluded (Mokhlesi, 
Kryger et al. 2008).  
Clinical features of OHS are similar to OSA consisting of hypersomnia and headache when 
awake, snoring and disturbed sleep (Casey, Cantillo et al. 2007). Pathogenesis is likely to be 
multifactorial. Reduction in respiratory compliance and lung volume, effects of leptin on 
central ventilatory drive, inspiratory muscle fatigue and depressed central ventilator control 
from sleep disturbances and raised PaCO2 on central ventilation are likely to play a role in 
this condition (Casey, Cantillo et al. 2007). Non-invasive positive pressure ventilation is 
effective and well tolerated in treating this condition (Mokhlesi and Tulaimat 2007; Priou, 
Hamel et al. 2010).  
4.1.4 Smoking 
Smoking causes adverse effects on health. The most common respiratory diseases associated 
with smoking are increased risk of chronic obstructive pulmonary disease and bronchogenic 
carcinoma. Smoking also increases risk of cardiovascular disease leading to myocardial 
infarction and peripheral vascular disease. Obese patients are already at higher risk of 
developing various health problems so these patients should be encouraged and assisted to 
stop smoking to help improve life expectancy (Scottish Intercollegiate Guidelines and 
Scotland 2010). It is recommended that patients should quit smoking at least 8 weeks prior 
to surgery to help reduce risk of respiratory complications (Mechanick, Kushner et al. 2009). 
Unfortunately, smoking cessation is associated with weight gain (Williamson, Madans et al. 
1991; Flegal, Troiano et al. 1995; Wise, Enright et al. 1998; Scottish Intercollegiate Guidelines 
and Scotland 2010) and patients might be reluctant to quit (McClean, Kee et al. 2008). 
Weight gain from smoking cessation is more pronounced in females compared to males 
(Williamson, Madans et al. 1991; Wise, Enright et al. 1998). Mean weight gain is between 
2.8kg (Williamson, Madans et al. 1991) to 5kg (Flegal, Troiano et al. 1995; Wise, Enright et al. 
1998) with females gaining approximately 1kg more than males (Williamson, Madans et al. 
1991). A proportion of patients will gain more than 13kg in weight (Williamson, Madans et 
al. 1991). Weight gain from quitting smoking has been associated with increased in 
prevalence in overweight population (Flegal, Troiano et al. 1995) and this could lead to 
obesity in the future. Although there is risk of weight gain, the benefits from smoking 
cessation is greater in improvement in lung function in particular FEV1 and FVC (Wise, 
Enright et al. 1998). The Framingham Heart Study found that obese smokers have almost 
doubled the reduction in life expectancy as compared to obese non smokers (Peeters, 
Barendregt et al. 2003). 
Patient should be given advice to seek help for smoking cessation. The reasons for weight 
gain might be due to various mechanisms. An increased in food consumption (2010) of up to 
250 to 300 kilocalories a day after stopping smoking, reduction in physical activity 
(Chiolero, Faeh et al. 2008), changes in fat metabolism e.g. lipoprotein activity (Williamson, 
Madans et al. 1991; Chiolero, Faeh et al. 2008) and changes in insulin homeostasis 
(Williamson, Madans et al. 1991) could all contribute to weight gain. Patients should be 
advised have low calorie diet, reduce in portion sizes during meal times and avoid second 
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helpings (2008). Chewing gum or nicotine gum helps to prevent snacking. Dietary advice on 
healthy balanced diet and increase in physical activities, getting new hobbies to relieve 
boredom are some simple advice for patients to stop smoking (2008). Individualised 
treatment plan with dietary and cognitive behavioural intervention will help potential 
quitters prevent weight gain (Scottish Intercollegiate Guidelines and Scotland 2010). 
Buproprion helps with weight loss (Davtyan and Ma 2008) and this could be use along side 
with nicotine replacement therapy. Smokers tend to have a longer hospital stay and 
smoking cessation should be recommended well in advance of bariatric surgery. 
4.2 Cardiovascular status 
Obesity increases risk for cardiovascular disorder (Hubert, Feinleib et al. 1983; Jonsson, 
Hedblad et al. 2002; Wilson, D'Agostino et al. 2002; Wolk, Berger et al. 2003) and premature 
death (Jonsson, Hedblad et al. 2002; Peeters, Barendregt et al. 2003) but is not a risk factor for 
post-operative cardiac complication (Mechanick, Kushner et al. 2009). Blood pressure 
monitoring to assess for hypertension and electrocardiography are basic investigations to 
assess cardiovascular function. Cardiac sounding chest pain or angina episodes should be 
investigated further, but investigations are limited given body habitus and lack of resolution 
of diagnostic tests. Difficulties lie with patient complaining of dyspnoea as this could 
present as cardiac disease or obesity related dyspnoea. Exercise tolerance will be useful to 
assess cardiac risk. Presence of other metabolic risk factors especially diabetes mellitus 
increases the patient’s risk for coronary artery disease (Fox, Coady et al. 2007). 
4.2.1 Electrocardiogram (ECG) 
Obesity may cause changes in ECG readings. Some common changes include left axis 
deviation likely due to displacement of the heart from raised diaphragm due to abdominal 
visceral fat and small voltages (Eisenstein, Edelstein et al. 1982; Frank, Colliver et al. 1986; 
Alpert, Terry et al. 2000; Poirier, Giles et al. 2006) from the increased distance between the 
heart and the chest wall (Poirier, Giles et al. 2006). Cardiac work load is also increased 
(Lavie, Milani et al. 2009) and this could lead to left ventricular hypertrophy (Lauer, 
Anderson et al. 1991; Poirier, Giles et al. 2006; Avelar, Cloward et al. 2007; Lavie, Milani et 
al. 2009; Movahed, Martinez et al. 2009). Pulmonary diseases such as obstructive sleep 
apnoea could cause cor pulmonale changes. Other possible ECG changes are increased in 
heart rate (Frank, Colliver et al. 1986; Poirier, Giles et al. 2006), prolonged PR interval 
(Frank, Colliver et al. 1986; Poirier, Giles et al. 2006; Seyfeli, Duru et al. 2006), prolonged 
QRS interval (Frank, Colliver et al. 1986; Poirier, Giles et al. 2006), prolonged QTc interval 
(Frank, Colliver et al. 1986; Alpert, Terry et al. 2000; Pontiroli, Pizzocri et al. 2004; Poirier, 
Giles et al. 2006; Arslan, Yiginer et al. 2010), ST-T wave abnormalities (Frank, Colliver et al. 
1986; Poirier, Giles et al. 2006) and flattening of the T wave especially in the inferolateral 
leads (Eisenstein, Edelstein et al. 1982; Alpert, Terry et al. 2000; Lopez-Jimenez and Cortes-
Bergoderi 2011). 
4.2.2 Echocardiography 
Technical difficulty in echocardiography is common in obese patients due to the size as well 
as the distance between chest wall and heart. Obesity increases the risk of left ventricular 
hypertrophy (LVH) (Lauer, Anderson et al. 1991; de la Maza, Estevez et al. 1994; Poirier, 
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Giles et al. 2006; Avelar, Cloward et al. 2007; Lavie, Milani et al. 2009; Movahed, Martinez et 
al. 2009) and this could be assessed using echocardiography. Presence of LVH increase risk 
of mortality as it is associated with coronary heart disease and stroke(Benjamin and Levy 
1999). Other potential abnormality include left atrial enlargement (Lavie, Milani et al. 2009; 
Arslan, Yiginer et al. 2010), difficulty in the assessment of pericardial fluid due to thickened 
epicardial tissue (Poirier, Giles et al. 2006). Dobutamine stress echocardiography is probably 
more useful than conventional echocardiogram to assess cardiac function (Mechanick, 
Kushner et al. 2009). 
4.2.3 Hypertension 
Hypertension is a well-recognised risk factor for coronary artery disease (Kannel 1996; Diaz 
2002; I 2010). Prevalence of hypertension is higher among overweight and obese 
population(Stamler, Stamler et al. 1978; Brown, Higgins et al. 2000) and is not associated 
with ethnicity or socioeconomic status (Diaz 2002). Indeed, increased in visceral abdominal 
fat in obesity increases the risk of hypertension (Narkiewicz 2006). Uncontrolled 
hypertension with blood pressure levels above 180/110mmHg should be corrected as this 
could lead to perioperative ischaemic events (Mechanick, Kushner et al. 2009). 
Many mechanisms have been postulated for the causation of hypertension and this includes 
changes in substances released from adipose tissue (Benjamin and Levy 1999; I 2010), 
increased in sympathetic activity (Narkiewicz 2006; Poirier, Giles et al. 2006, Wilcox 2010) 
and presence of obstructive sleep apnoea (Diaz 2002; Avelar, Cloward et al. 2007). Increase 
in body weight leads to increase in sympathetic activity (Narkiewicz 2006; Poirier, Giles et 
al. 2006; Wilcox 2010); and this could be explained by the activation of renin-angiotensin-
aldosterone system (Narkiewicz 2006; Wilcox 2010). Hypoxaemia and hypercapnic episodes 
as well as changes in the intrathoracic pressure in obstructive sleep apnoea has been found 
to increase blood pressure (Diaz 2002; Avelar, Cloward et al. 2007). 
Adipose tissue releases several adipokines (Maenhaut and Van de Voorde 2011). One 
adipokine is the hormone leptin (Wilcox 2010; Maenhaut and Can de Voorde 2011). Leptin 
levels are elevated in hypertension and its effect could be via the activation of the 
sympathetic nervous system or dysfunction of the endothelium causing vasoconstriction 
leading to increase in peripheral vascular resistance (Maenhaut and Van de Voorde 2011). 
Apart from increased risk in coronary heart disease, hypertension also increases the risk of 
developing renal failure (Narkiewicz 2006; Wilcox 2010). It is important to treat this 
condition vigilantly to prevent perioperative ischaemic event (Mechanick, Kushner et al. 
2009). Many guidelines are available as references for the treatment of hypertension such as 
the JNC VII report (Chobanian, Bakris et al. 2003) and British Hypertension Society 
guidelines (Williams, Poulter et al. 2004). 
4.2.4 Coronary heart disease 
Obesity increases the risk of myocardial infarction and coronary heart disease and is an 
independent risk factor for cardiovascular disease (Hubert, Feinleib et al. 1983; Wilson, 
D'Agostino et al. 2002). Given that there is increasing prevalence in hypertensive patients 
and obesity related obstructive sleep apnoea as well as increased risk of dyslipidaemia 
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and insulin resistance, these factors most likely contribute to the cumulative risks for 
obese patients (Poirier, Giles et al. 2006; Lopez-Jimenez and Cortes-Bergoderi 2011). Apart 
from this, it has been found that in young men, obesity could accelerate the development 
of atherosclerosis (McGill, McMahan et al. 2002). Patients with cardiac sounding chest 
pain or any previous history of cardiac disease should not be taken lightly prior to 
surgery and should be investigated thoroughly by a cardiologist and treated accordingly 
to minimise risk during surgery. Prophylactic beta-blocker therapy has been 
recommended for patients who have high risk of cardiac disease (Mechanick, Kushner et 
al. 2009). 
4.3 Metabolic control 
A high proportion of patients with obesity suffer from metabolic syndrome. Diagnosis of 
metabolic syndrome is based on the presence of insulin resistance, obesity, dyslipidaemia, 
and hypertension. Both International Diabetes Federation (IDF) (Alberti, Zimmet et al. 2005) 
and National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III)(2002) 
have their own criteria for metabolic syndrome as summarized below: 
 
 Obesity Lipid Blood pressure Glucose 
IDF – 
Obesity  
plus 2 
factors 
Waist circumference 
(ethnic specific) 
> 94cm (M) or 
> 80cm (F) 
Raised Tg ≥ 150mg/dl 
or  
HDL < 50 (M)  
or  
< 40mg/dl (F) 
or on therapy 
≥130/85 
mmHg  
or on therapy 
Fasting glucose 
> 100mg/dl  
or known 
diabetes 
mellitus 
NCEP 
ATP III 
-any 3 
criteria 
Waist circumference
> 102cm/40 inches (M) 
or 
> 88cm/35 inches (F) 
Raised Tg ≥ 150mg/dl 
or  
HDL < 40mg/dl (M)   
or  
< 50mg/dl (F)  
or on therapy 
≥130/85mmHg 
or on therapy 
Fasting glucose 
> 110mg / dl 
or known 
diabetes 
mellitus 
M=Male; F=Female 
Table 1. Criteria for metabolic syndrome 
4.3.1 Diabetes mellitus 
Obesity can cause insulin resistance due to changes in adipokines, inflammatory 
mechanisms and intrinsic cell mechanisms (Qatanani and Lazar 2007). Insulin resistance 
could in turn lead to development of diabetes mellitus (Chan, Rimm et al. 1994; Koh-
Banerjee, Wang et al. 2004). Raised visceral or waist to hip ratios (Chan, Rimm et al. 1994; 
Koh-Banerjee, Wang et al. 2004) and duration of obesity (Wannamethee and Shaper 1999) 
are good predictors of diabetes mellitus. Many individuals might already have diagnoses of 
diabetes mellitus and the rest needs to be screened with either fasting plasma glucose, 
HbA1c or a formal oral glucose tolerance test. 
Diagnosis of diabetes could be made by the presence of either one of the following based on 
the American Diabetes Association criteria (ADA) (2011): 
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 HbA1c ≥ 48mmol/mol or 6.5% 
 Fasting plasma glucose ≥ 126mg/dl or 7.0mmol/l 
 Oral glucose tolerance test after 75g of oral glucose with a result of fasting plasma 
glucose of ≥ 126mg/dl or 7.0mmol/l or 2 hour post-prandial reading of ≥200 mg/dl or 
11.1mmol/l. 
 Random plasma glucose of ≥ 200mg/dl or 11.1mmol/l with classical symptoms of 
hyperglycaemia or hyperglycaemia crisis such as hyperglycaemic hyperosmolar state or 
diabetic ketoacidosis. 
Newly diagnosed patients with diabetes mellitus should be managed appropriately. 
Lifestyle measures are usually the first step (Nathan, Buse et al. 2009; National Institute for 
et al. 2009). ADA and European Association of Study of Diabetes (EASD) (Nathan, Buse et 
al. 2009) as well as National Institute for Health and Clinical Excellence (NICE) (2009) have 
published guidelines for the management of type 2 diabetes mellitus. There are various 
different medications for diabetes mellitus and are associated with their own adverse effects 
including drug induced weight gain (Makimattila, Nikkila et al. 1999). A summary of the 
medications with effects on HbA1c, weight and adverse effects is as below (Nathan, Buse et 
al. 2009; Dicker 2011): 
 
Anti-diabetic medications 
Reduction in 
HbA1c (%) 
Effects on 
weight 
Other adverse side effects 
Biguanides 
Eg. Metformin 
1.0 – 2.0 Weight neutral
Gastrointestinal side effects, 
rarely lactic acidosis 
Sulphonylureas 
Eg. gliclazide, glipizide, 
glibenclamide 
1.0 – 2.0 Weight gain Hypoglycaemia 
α-glucosidase inhibitors 
Eg. Acarbose 
0.5 - 0.8 Weight neutral
Gastrointestinal side 
effects 
Glucagon like peptide (GLP)-1 
Eg. exenatide, liraglutide 
0.5 - 1.0 Weight loss Nausea, vomiting 
Pramlintide 0.5 - 1.0 Weight loss 
Gastrointestinal side 
effects 
Glinides 
Eg. repaglinide and nateglinide
0.5 – 1.5 Weight gain 
Gastrointestinal side 
effects 
Insulin 1.5 - 3.5 Weight gain Hypoglycaemia 
Thiazolidinediones 
Eg. pioglitazone, rosiglitazone*
0.5 - 1.4 Weight gain 
Fluid retention, *increased 
cardiovascular risk 
Dipeptidyl peptidase 4 (DPP-4) 
inhibitor(Dicker 2011) 
Eg. sitagliptin, saxagliptin, 
vildagliptin 
0.43 - 1.4 Weight neutral
Upper respiratory tract 
infection, nasopharyngitis, 
headache 
 
*Rosiglitazone is associated with increased cardiovascular risk and is withdrawn in the United 
Kingdom (2010) and in europe (2010). United States Food and Drug Administration (FDA) have issued 
restriction on its usage (2011).  
Table 2. HbA1c, weight and adverse effects of anti-diabetic medications (Nathan, Buse et al. 
2009; Dicker 2011) 
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It is recommend to have a HbA1c level of < 53mmol/mol or 7.0% (Mechanick, Kushner et al. 
2009; 2011), fasting plasma glucose of < 110mg/dl or 6.1mmol/l (2011) preoperatively to 
ensure good outcome. This, however, is unrealistic in many patients who are having 
bariatric surgery to treat their poor diabetes control. There is a greater propensity for day 
case and short stay bariatric surgery which allows patients with less well-controlled diabetes 
to have bariatric surgery. 
4.3.2 Dyslipidaemia 
Increased in visceral adipose tissue in obesity is associated with raised triglyceride levels, 
raised small dense low density lipoprotein (sdLDL) and reduction in high density 
lipoprotein cholesterol (HDL) levels (Ginsberg and Maccallum 2009; Athyros, Tziomalos et 
al. 2011). In addition, presence of insulin resistance as previously described can further 
increased free fatty acids availability to other organs (Athyros, Tziomalos et al. 2011). 
Guidelines such as the National Cholesterol Education Program on adult treatment panel III 
(NCEP ATP III) (2002) and NICE guidelines on lipid modifications (2010) are useful to help 
treat and reduce cardiovascular risk. 
4.4 Gastrointestinal (GI) status 
Presence of any gastrointestinal (GI) symptoms should warrant further evaluation with 
additional investigations (Mechanick, Kushner et al. 2009). Gastroenterology referral is 
appropriate and endoscopy could be performed to rule out serious diseases. It is important 
to note that obesity is associated with a number of cancers. Physicians should be vigilant to 
distinguish between healthy planned weight loss and weight loss due to sinister reasons 
such as cancer. 
4.4.1 Common gastrointestinal problems in obesity 
There appears to be a positive correlation between obesity and gastrointestinal symptoms 
especially abdominal pain, vomiting and diarrhoea (Delgado-Aros, Locke et al. 2004; Talley, 
Howell et al. 2004). It is still unclear as to the mechanisms causing these symptoms 
(Delgado-Aros, Locke et al. 2004; Talley, Howell et al. 2004). Other upper GI symptoms 
could be caused by gastroesophageal reflux disease (GERD). GERD is a common disorder 
and patients present with different symptoms including heartburn, acid regurgitation, chest 
pain, dysphagia and dyspepsia (Locke, Talley et al. 1997). One of the major risk factor for 
GERD is obesity (El-Serag, Graham et al. 2005; Corley and Kubo 2006). Oesophageal 
erosions are also more prevalent in obese patients (El-Serag, Graham et al. 2005). This is 
important as symptomatic GERD is associated with future development of Barrett’s 
oesophagus and oesophageal adenocarcinoma (Lagergren, Bergstrom et al. 1999). Therefore 
it is important to treat this condition adequately either through medical therapies or weight 
loss through surgery. 
4.4.2 Gallstones 
Gallstones disease is common in obese population and could cause abnormality in liver 
enzyme levels. Rapid weight loss post bariatric surgery especially with Roux-en-Y gastric 
bypass surgery is associated with biliary stasis and lithiasis (Caruana, McCabe et al. 2005; 
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Quesada, Kohan et al. 2010). Patients could have concomitant cholecystectomy during 
surgery with disadvantage of increased in intrasurgical time or treat with prophylactic 
ursodeoxycholic acid post surgery for 6 months (Quesada, Kohan et al. 2010). 
4.4.3 Non-alcoholic fatty liver disease 
Obesity is one of the major risk factor for non-alcoholic fatty liver disease (NAFLD) (Clain 
and Lefkowitch 1987; Salgado Junior, Santos et al. 2006; Scaglioni, Ciccia et al. 2011) and is 
often asymptomatic (Salgado Junior, Santos et al. 2006). Abnormal liver function test results 
especially with raised aspartate transaminase (AST) and AST/ALT (alanine transaminase) 
ratio are some predictors of this disease (Liew, Lee et al. 2006; Salgado Junior, Santos et al. 
2006). Viral, autoimmune and other rare causes such as Wilson’s disease and alpha-1 
antitrypsin deficiency should be ruled out in the presence of abnormal test results. Other 
laboratory abnormalities are raised γ- glutamyltransferease (γGT) and alkaline phosphatase 
(ALP), dyslipidaemia and hyperglycaemia (Salgado Junior, Santos et al. 2006). Liver biopsy 
is the gold standard for diagnosing this condition (Salgado Junior, Santos et al. 2006; 
Vuppalanchi and Chalasani 2009). Ultrasound scan of the liver (Mechanick, Kushner et al. 
2009) or liver biopsy(Salgado Junior, Santos et al. 2006)is recommended in the presence of 2-
3 folds increased in the liver enzymes. Transient elastography (Lupsor, Badea et al. 2010) 
including using XL probe for obese patients (Myers, Pomier-Layrargues et al. 2011) is an 
alternative method in assessing liver stiffness hence able to detect liver fibrosis. Hepatotoxic 
medications should be avoided in these patients (Salgado Junior, Santos et al. 2006) and 
bariatric surgery can potentially reverse the condition (Srivastava and Younossi 2005; De 
Ridder, Schoon et al. 2007; Kaila and Raman 2008). 
4.4.4 Alcohol 
Alcohol is another common cause for abnormal liver function test results and excessive 
intake could potentially cause liver problems including cirrhosis. In a study, it is found that 
overweight and obese individuals have higher risk of raised liver enzymes with only 2 
alcohol drinks per day (Ruhl and Everhart 2005). Current history of excess alcohol use is 
contraindicated for bariatric surgery (Snyder 2009) and these patients should be referred to 
other services to help quit. Patients undergoing bariatric surgery need to be counselled 
regarding alcohol. Total abstinence is not necessary as in gastric band patients, those who 
are teetotal appear to lose less weight (Dixon, Dixon et al. 2001). Alcohol absorption is 
greater in malabsorptive type operations and patients should be warned that there are risks 
of rapid intoxication and greater liver damage by alcohol. 
4.5 Endocrine disorders causing obesity  
A small proportion of patients’ weight problem might be due to endocrine disorders 
especially for patients with history of recent weight gain. The common disorders include 
hypothyroidism, Cushing’s syndrome and prolactinoma. Hypothyroidism is associated with 
weight gain through reduction in metabolic rate and thermogenesis (Reinehr 2010). 
Associations have been found between obesity and thyroid function especially elevation in 
thyroid stimulating hormone (TSH) (Knudsen, Laurberg et al. 2005; Nyrnes, Jorde et al. 
2006). This is likely to help in increasing energy expenditure leading to reduction in fat 
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deposition (Reinehr 2010). Furthermore, obesity is associated with reduced tissue 
conversion of T4 to T3. It should be noted that in up to 30% of patients with thyroid 
overactivity, weight gain may occur rather than weight loss.  
Hyperprolactinaemia could lead to increase in weight as shown in patients with 
prolactinomas. When prolactin levels fall after treatment so does patients’ weight 
(Greenman, Tordjman et al. 1998). The relationship between prolactin level and weight 
could be due to the changes within central dopaminergic pathway and reduction in 
serotonin secretion(Kopelman 2000). Prolactin level has been found to be elevated in 
obese females (Kok, Roelfsema et al. 2004) and levels falls after weight loss (Kok, 
Roelfsema et al. 2006). Raised prolactin level in obesity might be a result of 
hyperinsulinaemic state or alterations in doperminergic and serotoninergic activities 
centrally (Kopelman 2000).  
Cushing’s syndrome is a condition of chronic excessive glucocorticoid production. This 
condition causes weight gain amongst other clinical features as described above. In patients 
with morbid obesity, mild hypercortisolaemia could be found with increased  urinary free 
cortisol level (Nieman, Biller et al. 2008). Other conditions mimicking Cushing’s syndrome 
are chronic alcoholism, major depressive disorder (Orth 1995), poorly controlled diabetes 
mellitus, and pregnancy (Nieman, Biller et al. 2008). One should always keep in mind these 
potential endocrine abnormalities causing obesity and investigate further in suspicious 
cases.  
4.6 Reproductive status  
In males, increased in BMI is associated with fertility problems (Nguyen, Wilcox et al. 
2007) and this could be related to reduction in testosterone, sex hormone binding globulin 
(SHBG) and free testosterone as weight increases (MacDonald, Herbison et al. 2010). 
Oestradiol level on the other hand is increased (Hammoud, Gibson et al. 2009) and this is 
likely caused by aromatisation of adipose tissue. Hormonal changes are likely to cause 
problems with sexual quality of life and this can be reversed with bariatric surgery 
(Hammoud, Gibson et al. 2009). 
In females, high body mass index could cause problem with menstrual irregularities (Jones, 
Srinivasan et al. 2007; Wei, Schmidt et al. 2009; Kulie, Slattengren et al. 2011). The 
underlying cause could be due to polycystic ovarian syndrome, oligomenorrhoea or 
amenorrhoea (Jones, Srinivasan et al. 2007) leading to issues with ovulation. Links have 
been found between increased abdominal fat with anovulation (Kuchenbecker, Groen et al. 
2010) likely due to insulin resistance (Pasquali, Pelusi et al. 2003). These problems in turn 
lead to sub- or infertility by disrupting spontaneous ovulation and can reduced efficacy of 
assisted fertility treatment (Pasquali, Pelusi et al. 2003; Balen 2007; Farquhar 2007; Pasquali, 
Patton et al. 2007). However, fertility is improved post bariatric surgery due to weight loss 
(Guelinckx, Devlieger et al. 2009; Shah and Ginsburg 2010; Hezelgrave and Oteng-Ntim 
2011; Kulie, Slattengren et al. 2011). Early pregnancy post surgery might be associated with 
increased risk of miscarriages and possibility of preterm birth (Guelinckx, Devlieger et al. 
2009). Therefore, patients suitable for surgery are generally advised not to seek pregnancy at 
least 1 year after surgery (Guelinckx, Devlieger et al. 2009; Mechanick, Kushner et al. 2009). 
This is especially important in patients receiving malabsorptive surgeries as there are 
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potentially severe nutritional deficiencies that could be exacerbated in pregnancy 
(Guelinckx, Devlieger et al. 2009; Hezelgrave and Oteng-Ntim 2011). 
Contraception advice is vital. Obesity is a risk factor for venous thromboembolism (Stein, 
Beemath et al. 2005) and can cause recurrent thromboses (Eichinger, Hron et al. 2008). 
Oestrogen therapy is recommended to be stopped a month prior to surgery to avoid this 
complication (Mechanick, Kushner et al. 2009). Individuals going for malabsorptive 
procedures should be advice to avoid oral contraception as post operative as there is a risk 
of failure to absorb leading to failure of treatment (2010; Paulen, Zapata et al. 2010). There 
are concerns as well regarding risk of fractures due to effects on bone mineral density from 
usage of depot medroxyprogesterone acetate (DMPA) after malabsorptive surgery (Paulen, 
Zapata et al. 2010). 
4.7 Medications causing weight gain 
The commonest cause of weight gain is due to adverse effect from drug therapy and 
patients should be advised on weight gain when these medications are prescribed (Scottish 
Intercollegiate Guidelines and Scotland 2010). Common medications causing weight gain 
are as follows (Kulkarni and Kaur 2001; Ness-Abramof and Apovian 2005; Leslie, Hankey et 
al. 2007; Davtyan and Ma 2008; Scottish Intercollegiate Guidelines and Scotland 2010; 
Nihalani, Schwartz et al. 2011): 
- Anti-convulsants (sodium valproate, carbamazepine, gabapentin) 
- Anti-psychotics (clozapine, olanzapine, risperidone, quetiapine, clopromazine, 
ziprasidone, aripiprazole) 
- Anti-depressants (tricyclic anti-depressants (TCA), selective serotonin reuptake 
inhibitors (SSRI), mirtazapine) 
- Mood stabilisers (lithium) 
- Anti-hypertensives (beta blockers, calcium channel blockers) 
- Anti-diabetic medications (insulin, sulphonylurea, thiazolidinedione) 
- Steroid 
- Anti-neoplastic agents (tamoxifen) 
- Anti-histamines 
Mechanisms of medications causing weight gain could be due to their effects on appetite 
through receptors at the central nervous system or effects on the body’s metabolism. Anti-
histaminergic effect by most psychotropic medications including anti-depressants and 
anti-psychotics causes cravings for carbohydrate (Davtyan and Ma 2008; Nihalani, 
Schwartz et al. 2011). Antipsychotics cause inhibitory effect on serotonin and epinephrine 
receptors thus stimulating appetite (Davtyan and Ma 2008). These effects could cause 2 to 
17kg of weight gain during treatment (Nihalani, Schwartz et al. 2011). Lithium is used as 
mood stabilisers and might cause weight gain through increasing level of serum leptin 
(Atmaca, Kuloglu et al. 2002) or changes in thyroid function. As many obese patients 
suffer from depression, medications to treat the condition could be a cause of obesity or 
exacerbate the problem. Venlafaxine is weight neutral while bupropion causes weight loss 
so could be treatment of choice if patient is not contraindicated to these medications 
(Davtyan and Ma 2008).  
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Anticonvulsants cause weight gain through the effects on endocrine system and body 
metabolism. Sodium valproate causes increase in insulin and leptin levels with reduction in 
gluconeogenesis and metabolic rate (Davtyan and Ma 2008). Alternative medication using 
weight neutral anticonvulsants such as lamotrigine (Kulkarni and Kaur 2001) and 
levetiracetam (Davtyan and Ma 2008) could help prevent the problem, and topiramate may 
help induce weight loss (Kulkarni and Kaur 2001; Davtyan and Ma 2008). 
Beta adrenergic receptors are present in adipose tissue and when stimulated by 
noradrenaline, help to metabolize fat into energy source (Nihalani, Schwartz et al. 2011). 
Beta blocker not only reverses this effect, it also causes reduction in resting metabolic rate 
(Davtyan and Ma 2008). Verapamil might cause weight gain through inhibition in 
dopaminergic receptor while clonidine reduces sympathetic activity via central nervous 
system thus decreasing the metabolic rate (Davtyan and Ma 2008). Angiotensin converting 
enzyme (ACE) inhibitors and diuretics are other possibilities as treatment for hypertension 
(Davtyan and Ma 2008). 
Obesity is associated with metabolic syndrome and this causes insulin resistance leading to 
diabetes mellitus. Some anti-diabetic medications causes weight gain mostly through effect 
on metabolism. Correction of catabolic state of diabetes causing retention of calories, 
endogenous or exogenous insulin causing inhibition of lipolysis, reduction in leptin 
production and appetite stimulation from hypoglycaemic episodes contributes towards 
weight gain (Davtyan and Ma 2008). One of the side effects of thiazolidinediones is fluid 
retention (Davtyan and Ma 2008). Medications helping in weight loss is glucagon-like 
peptite-1 (GLP-1) (Nathan, Buse et al. 2009) while dipeptidyl-peptidase (DPP)-4 inhibitor 
(Dicker 2011), gliclazide modified release (Zoungas, Chalmers et al. 2010) and 
metformin(Nathan, Buse et al. 2009) are weight neutral . These might be better choice for 
obese patients if there are no contraindications. It is important to recognise drug induced 
weight gain and sometimes changing medications could enhance potential weight lost post 
surgery. 
5. Psychological assessment 
All patients who undergo surgery will need long term behavioural and eating habit 
changes. Indeed, some view bariatric surgery as a forced behavior modification (van Hout 
and van Heck 2009). Psychological and psychiatric disorders could lead to a negative 
outcome post operatively (Pull 2010). These include those who have active psychosis, 
current illicit drug users or alcohol abuse and personality disorders(Susan F. Franks 2008). 
Surgery is contraindicated in patients who are currently abusing drugs or alcohol (Susan F. 
Franks 2008; Snyder 2009). Patients with previous history of sexual abuse, found in a 
significant percentage of bariatric patients, will need more support as they might find 
difficulties with attention gained post surgery due to change in body image and thus risk 
regaining weight(Snyder 2009). Psychological disorders can include depression, anxiety, 
eating disorders and low self esteem (Abiles, Rodriguez-Ruiz et al. 2010). Patients known or 
suspected to have psychological or psychiatric disorders should be referred for further 
mental health assessment (Susan F. Franks 2008; Mechanick, Kushner et al. 2009) by a 
psychologist or psychiatrist. The assessment usually contains one or two parts: a clinical 
interview and psychological testing (Mechanick, Kushner et al. 2009; Snyder 2009). 
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5.1 Depression and anxiety 
Depression is very common (Susan F. Franks 2008; Snyder 2009; Abiles, Rodriguez-Ruiz et 
al. 2010) and prevalence is highly variable depending on the use of a choice of structured 
clinical interview for diagnostic and statistical manual of mental disorders (SCID) or clinical 
based diagnosis (Susan F. Franks 2008). Mild depressive disorder is relatively benign and 
might improve post surgery (Snyder 2009). On the other hand, severe depression with or 
without suicidal ideation could have adverse effects towards patients as they might have 
difficulty adhering with dietary or other advice provided(Snyder 2009). Patients will need 
these addressed prior to surgery (Mechanick, Kushner et al. 2009). 
Anxiety is present in 15 to 37.5% of patients (Susan F. Franks 2008). Most patients’ distress 
levels are reduced with weight loss post surgery (Ryden, Karlsson et al. 2003) but this could 
potentially cause problems with adaptability or ability to cope perioperatively (Snyder 2009). 
5.2 Eating disorder 
Eating disorder is common. This can include comfort eating from emotional stress or 
distress, binge eating, snacking (Mechanick, Kushner et al. 2009; Snyder 2009) and night 
time eating (Snyder 2009). Binge eating is characterised by subjective loss of control and 
consumed a large quantity of food within a short period (Snyder 2009). About 10-25% of 
patients have problems with binge eating (Snyder 2009). Psychologists could help alleviate 
the symptoms and reinforce the behaviour modification needed (Snyder 2009).  
Night eating syndrome (NES) is characterised with night time hyperphagia, which is intake 
of 25% of total daily calories after evening meal, awaking from sleep to eat at night (Allison, 
Wadden et al. 2006; Howell, Schenck et al. 2009; Stunkard, Allison et al. 2009) and morning 
anorexia (Gluck, Geliebter et al. 2001). It is more common in women, and is associated with 
higher rate of depression, lower self-esteem and less day time hunger with poorer outcome 
in weight loss (Gluck, Geliebter et al. 2001). Patients with this condition should be 
considered for a referral to a psychologist for further evaluation and treatment. Sertraline 
has been shown to be useful in patients with night eating syndrome (O'Reardon, Allison et 
al. 2006). 
Psychological assessments will help to distinguish patient who are contraindicated for 
surgery, improve patient’s emotional well being and motivation as well as enhances 
patient’s ability to cope with bariatric surgery (Snyder 2009). 
6. Dietary and nutrition assessment 
Food can be measured based on amount of calories. Weight is maintained when intake of 
calories equals expenditure. Obesity occurs when there is a chronic surplus of intake. 
Therefore, nutritional assessment by a specialist dietitian or nutritionist is essential. 
Assessment should again be holistic and this includes patient’s lifestyle, eating habits, 
positive and negative influences on behaviour (Detitians in obesity management 2007). 
Practitioners should have specialist skills in nutritional assessment. Time recommended to 
evaluate lifestyle habits is initially is between 45 minutes and an hour with follow up 
appointments between 20 to 30 minutes (Detitians in obesity management 2007). 
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The patient’s weight history could help identify onset of weight problem either since 
childhood indicating a genetic contribution (Farooqi and O'Rahilly 2007) or any important 
life events causing initiation of weight problem such as pregnancy (Smith, Lewis et al. 
1994). Assessment should also include previous efforts and outcomes of weight loss 
attempts. Gibbons et al showed that on average, individuals had 4.7 attempts in losing 
weight before seeking surgery (Gibbons, Sarwer et al. 2006). This enables positive factors 
to be identified and maintained and previous failures addressed (Detitians in obesity 
management 2007). 
Bariatric surgery will help in weight loss but Swedish Obese Subjects (SOS) study has 
shown that after maximum weight loss at 1 year, patients start to regain some of the excess 
weight loss after 2 years and weight gain stabilized after 8 to 10 years (Sjostrom, Narbro et 
al. 2007). Lifestyle modifications which include changes in diet, physical activity and 
behavioural therapy are paramount in preventing this problem post surgery and assist in 
weight maintenance (National Heart, Blood et al. 1998; Wadden, Butryn et al. 2007; Tsigos, 
Hainer et al. 2008). 
Apart from these, it is also important to look at cultural, religious and personal beliefs or 
preferences in different type of food and eating behaviour. The use of a food diary is an 
important tool to assess quantity and type of food intake as well as able to provide practical 
suggestions on changes (Detitians in obesity management 2007; Scottish Intercollegiate 
Guidelines and Scotland 2010). However, obese patients tend to under-report their dietary 
intake (Detitians in obesity management 2007; Scottish Intercollegiate Guidelines and 
Scotland 2010). 
6.1 Eating habits 
There are different dietary behaviours within the obese population. Some patients eat for 
comfort especially during stress or negative emotions (Elfhag and Rossner 2005). There are 
many different eating habits and detailed assessment of dietary intake is vital in providing 
specific action plans for different patients. Binge eating and night eating syndrome are 
eating disorders as described above (Allison, Wadden et al. 2006; Tsigos, Hainer et al. 2008). 
It is important to identify patients who have this problem and referred to psychologist for 
further treatment prior to proceeding for bariatric surgery (Detitians in obesity management 
2007). 
Skipping meals especially breakfast is a common habit (Ruxton and Kirk 1997; Wyatt, 
Grunwald et al. 2002). Breakfast especially with cereal is low in fat, high in carbohydrate, 
fibre and micronutrients (Ruxton and Kirk 1997). Researchers have shown breakfast 
consumption is associated with lower body weight (Ruxton and Kirk 1997) and better 
success with future maintenance of weight loss (Wyatt, Grunwald et al. 2002; Elfhag and 
Rossner 2005; Wing and Phelan 2005; Grief and Miranda 2010). Nevertheless, it is common 
for patients to not feel hungry in the morning after bariatric surgery. Other erratic eating 
habits include periods of fasting, snacking or grazing food (Detitians in obesity management 
2007). Sometimes the spouse or partner provides excessive feeding towards the patient 
causing excessive eating. It is important to address these behaviours and educate patients to 
have a balanced three meals per day to maintain good nutritional status prior to surgery 
(Tsigos, Hainer et al. 2008). 
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6.2 Dietary treatment 
There are various types of food in the shelves of supermarkets and consumers have many 
different choices. Most food packaging now carry nutritional information on their labels for 
consumers to read. Educating patients to choose their food can help increase further 
awareness of label reading. Furthermore, it is also a good opportunity to educate patient to 
have a more balanced diet consisting of more fruits and vegetables, and less fat, salt and 
sugar ((FDA) 2004; NHS Choices 2011). 
Nutritional requirements are different for each person depending on gender, height, weight, 
amount of physical activity and age. Dietitians could help to calculate the daily requirement 
while patients need to be taught how to read food label and perform their own calorie 
counting for their recommended daily calorie intake. 
There are many dietary interventions available. The Dietary Approaches to Stop 
Hypertension (DASH) for obese patient with hypertension gives priority to a diet high in 
grain products, fruits, vegetables, low in fat and non dairy food. It has proven to lower 
blood pressure (Appel, Moore et al. 1997; Svetkey, Simons-Morton et al. 1999; Miller, 
Erlinger et al. 2006) and cholesterol (Miller, Erlinger et al. 2006). Other interventions that has 
shown success in weight loss include carbohydrate restriction diet including commercial 
weight loss programme (Nordmann, Nordmann et al. 2006; Gardner, Kiazand et al. 2007), 
the low glycaemic index diet (Thomas, Elliott et al. 2007), Mediterranean diet (Shai, 
Schwarzfuchs et al. 2008) and low fat diet(Nordmann, Nordmann et al. 2006). 
6.3 Six hundred calorie deficit diet 
It is recommended for patient to aim to lose weight of no more than 0.5 – 1kg (1 – 2Ib) per 
week (Heart, Blood et al. 1997; 2006; Scottish Intercollegiate Guidelines and Scotland 2010) 
and this equivalent to a calorie deficit of 500 to 1000kcal per day for 6 months (National 
Heart, Blood et al. 1998; Scottish Intercollegiate Guidelines and Scotland 2010); hence the 
600kcal deficit approach (Detitians in obesity management 2007; Tsigos, Hainer et al. 2008; 
Scottish Intercollegiate Guidelines and Scotland 2010). Dietician will calculate the patient’s 
estimated energy requirement and subtract it by 600kcal per day resulting in a negative 
balance (Detitians in obesity management 2007). This could be individualised to each 
patients’ needs and preferences in food but should still maintain a healthy and balanced 
diet. 
6.3.1 Low energy and very low energy diets 
Patients who need to achieve a more rapid weight loss could try the more restricted calorie 
diet (Detitians in obesity management 2007; Tsigos, Hainer et al. 2008; Scottish 
Intercollegiate Guidelines and Scotland 2010). Low energy diet consists of total daily calories 
of between 800 to 1,500kcal and very low energy diet consists of less than 800kcal per day 
(National Heart, Blood et al. 1998; Detitians in obesity management 2007; Tsigos, Hainer et 
al. 2008; Scottish Intercollegiate Guidelines and Scotland 2010) or <50% reduction of the 
patient’s predicted resting energy expenditure (Tsai and Wadden 2006). Low energy diet is 
associated with 5–8% of weight loss (National Heart, Blood et al. 1998; Scottish 
Intercollegiate Guidelines and Scotland 2010) over 12 months and this could be 
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individualised to the patient’s food preference (National Heart, Blood et al. 1998). 
Micronutrient supplementations are occasional necessary. 
Very low energy diet (VLED) is usually a liquid diet consisting of a large amount of protein, 
up to 80g of carbohydrate and 15g of fat per day and fortified with micronutrients (Tsai and 
Wadden 2006). This intervention need to be done under close medical supervision (1993; 
Detitians in obesity management 2007; Tsigos, Hainer et al. 2008; Scottish Intercollegiate 
Guidelines and Scotland 2010). Maximum recommended duration of this intervention is 12 
weeks (Detitians in obesity management 2007). The patient needs to consume a minimum of 
2 litre of non-caloric fluid per day while on this diet (Tsai and Wadden 2006). Cambridge 
Weight Plan previously known as the Cambridge Diet uses VLED intervention. Adverse 
effects during this treatment include cholelithiasis, cold intolerance, hair loss, headache, 
fatigue, dizziness, muscle cramps, constipation, volume depletion and rarely cardiac 
complications causing death if unsupervised (1993; Tsai and Wadden 2006). Total weight 
loss at 12 months for VLED is similar to low calorie diet (National Heart, Blood et al. 1998; 
Tsai and Wadden 2006; Scottish Intercollegiate Guidelines and Scotland 2010). During first 3 
to 4 months, initial weight loss with VLED is about 25-50% but patient regained 40–50% of 
the weight lost within 1–2 years while on VLED (Tsai and Wadden 2006) hence it is suitable 
for rapid weight loss. One study showed remission of type 2 diabetes in obese patient after 8 
weeks of VLED (Lim, Hollingsworth et al. 2011). 
VLED with liquid diet or low energy diet substituted with one or two of the three daily 
main meals and this intervention is called meal replacement intervention (Tsigos, Hainer et 
al. 2008). As the liquid diet consists of necessary micronutrients, this may help in weight loss 
while maintaining a balanced nutrition (Tsigos, Hainer et al. 2008); the low energy diet 
replacement needed to be fortified with the necessary vitamins and minerals (Heymsfield, 
van Mierlo et al. 2003). It is shown that meal replacement intervention induce between 6.97 
to 7.31kg of weight loss at 1 year follow up as compared to 2.61-4.35kg with low energy diet 
alone (Heymsfield, van Mierlo et al. 2003). 
7. Lifestyle intervention 
After dietary changes in reducing calorie intake, the next step would be to increase in 
physical activity and finally help in engaging the patient for a more permanent change in 
lifestyle. Physical activity for about 30–60 min per day for at least 5 days a week of moderate 
intensity such as brisk walking has been recommended by various guidelines (National 
Heart, Blood et al. 1997; 2006; Tsigos, Hainer et al. 2008; Scottish Intercollegiate Guidelines 
and Scotland 2010). Increased physical activity has added effect on weight loss compared to 
just dietary interventions alone (Jakicic 2009; Goodpaster, Delany et al. 2010). It also 
improves cardiorespiratory fitness (National Heart, Blood et al. 1998), reduces 
cardiovascular risks (National Heart, Blood et al. 1998; Tsigos, Hainer et al. 2008; 
Goodpaster, Delany et al. 2010; Vetter, Faulconbridge et al. 2010), reduces abdominal fat 
(Jones, Wilson et al. 2007), improves anxiety and depression and helps with long term 
weight management(Jones, Wilson et al. 2007; Tsigos, Hainer et al. 2008; Jakicic 2009). 
Patients should also be encouraged to avoid sedentary lifestyle by choosing to use the stairs 
rather than elevators, walking or cycling to nearby places rather than driving and doing 
gardening (Vetter, Faulconbridge et al. 2010). 
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It has been shown by the Diabetes Prevention Programme (Knowler, Barrett-Connor et al. 
2002) and the Finnish Diabetes Prevention studies (Tuomilehto, Lindstrom et al. 2001) that 
intensive lifestyle interventions promote weight loss of between 3.5-5.6kg. The Look AHEAD 
trial reported 6.15% weight loss after 4 years of interventions (Wing 2010). Most of the 
academic centres provide initial weekly interventions for a period of 16 to 26 weeks (Wadden, 
Butryn et al. 2007; Vetter, Faulconbridge et al. 2010). The entire treatment programme should 
be well structured along the lines of the Diabetes Prevention Programme. It is also more cost 
effective to have group sessions. Moreover, group sessions provide additional benefits on 
greater initial weight loss, better social support and healthy competition between members 
(Wadden, Butryn et al. 2007; Vetter, Faulconbridge et al. 2010). 
Even after successful initial weight loss, weight regain could occur prior to surgery. Reasons 
behind weight regain are likely to be multifactorial including behavioural fatigue (Tsai and 
Wadden 2006), leaving from highly supportive care and return to initial ‘damaging’ 
environment or influence (Vetter, Faulconbridge et al. 2010). Hence health care professionals 
and patients should aim for long term behavioural change and it is the key in preventing 
weight regain prior and post surgery. 
8. Final steps prior to surgery 
After medical, psychological and nutritional assessments, the team will need to meet 
together to provide insight of the patients’ conditions and discuss suitability of surgical 
interventions in them. Some centres propose a minimum 5 - 10% weight loss prior to 
surgery as some studies have shown this decreases length of hospital stay (Still, Benotti et al. 
2007), reduces operative time (Huerta, Dredar et al. 2008) and less complications (Liu, Sabnis 
et al. 2005). As most of the dietary advice post surgery advises patients to have a liquid diet 
first, it is also important to review all patients’ medications pre-surgery and change 
medications into liquid or soluble form prior to surgery.  
9. Conclusion 
Assessing and preparing patients for bariatric surgery is a complex process requiring input 
from a multi-disciplinary team. The primary aim is to optimise treatment of patients’ pre-
existing conditions hence minimising peri and post-operative complications and mortality. 
The surgery itself is only the first step. Post operatively, bariatric team members as well as 
patients’ general practitioners need to continue to encourage patients’ adherence to lifestyle 
changes including dietary energy restriction and increase in physical activity to help in long-
term weight maintenance.  
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